Austin, TXNCT07093255Now EnrollingIRB Ready

Retinopathy of Prematurity (ROP) Clinical Trial in Austin, TX

Access cutting-edge retinopathy of prematurity (rop) treatment through this clinical trial at a research site in Austin. Study-provided care at no cost to qualified participants.

Sponsored by FELIQS INC.

Quick Self-Assessment

See if you qualify for this Austin location

Preparing your pre-screening questions…

Expert Care in Austin

Access retinopathy of prematurity (rop) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related retinopathy of prematurity (rop) treatment provided free

Apply for This Austin Location

Check if you qualify for this retinopathy of prematurity (rop) clinical trial in Austin, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Austin

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Austin site if eligible
  4. 4Begin participation

About This Retinopathy of Prematurity (ROP) Study in Austin

The purpose of this study is to evaluate safety and efficacy outcomes following exposure to FLQ-101.

Sponsor: FELIQS INC.

Who Can Participate

Inclusion Criteria

Written consent is obtained from parent(s) or legal guardian.
Neonates born at 26 weeks +0 days and 27 weeks +6 days of gestation.
Male or female infants with a birth weight greater than or equal to 650 gm.

Exclusion Criteria

Neonates with congenital malformation of the eye or any other ocular condition that may prevent or relevantly affect any of the assessments or procedures.
Neonates with serious congenital anomalies, severe congenital infection, and chromosomal abnormalities.
Neonates who are seriously ill and not expected to survive.
Neonates with heart disease, including cardiomyopathy, serious arrhythmias, and congenital heart disease. (Neonates with patent foramen ovale may be included in the study if clinically stable).
Neonates that are small for gestational age defined as having a weight \<10th percentile at birth based on the Fenton growth charts for gestational age and sex.
Neonates with history of or ongoing intraventricular hemorrhage (IVH) grades 2, 3 or 4. Neonates with IVH grade 1 may be included in the study at the discretion of the PI.
Neonates with any other medical conditions or clinically significant comorbidities or circumstances that in the opinion of the investigator may have a relevant impact on study participation or any of the study assessments or procedures.
Infants scheduled to participate in other interventional clinical trials while participating in the study and until reaching end of study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Austin?

Yes, this clinical trial (NCT07093255) has an active research site in Austin, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Retinopathy of Prematurity (ROP) Treatment Options in Austin, TX

If you're searching for retinopathy of prematurity (rop) treatment options in Austin, TX, this clinical trial (NCT07093255) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Austin research site is actively enrolling participants for this clinical trial. You'll receive care from experienced retinopathy of prematurity (rop) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all retinopathy of prematurity (rop) clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Austin, TX

See all essential tremor clinical trials recruiting in Austin — not just this study.

Browse Essential Tremor Trials in Austin →

Browse More Trials by Condition

Essential Tremor TrialsAll Conditions →

Ready to Join in Austin?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Austin, TX